首页> 美国卫生研究院文献>other >Physical Methods for Intracellular Delivery: Practical Aspects from Laboratory Use to Industrial-Scale Processing
【2h】

Physical Methods for Intracellular Delivery: Practical Aspects from Laboratory Use to Industrial-Scale Processing

机译:细胞内递送的物理方法:从实验室使用到工业规模加工的实用方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Effective intracellular delivery is a significant impediment to research and therapeutic applications at all processing scales. Physical delivery methods have long demonstrated the ability to deliver cargo molecules directly to the cytoplasm or nucleus, and the mechanisms underlying the most common approaches (microinjection, electroporation, and sonoporation) have been extensively investigated. In this review, we discuss established approaches, as well as emerging techniques (magnetofection, optoinjection, and combined modalities). In addition to operating principles and implementation strategies, we address applicability and limitations of various in vitro, ex vivo, and in vivo platforms. Importantly, we perform critical assessments regarding (1) treatment efficacy with diverse cell types and delivered cargo molecules, (2) suitability to different processing scales (from single cell to large populations), (3) suitability for automation/integration with existing workflows, and (4) multiplexing potential and flexibility/adaptability to enable rapid changeover between treatments of varied cell types. Existing techniques typically fall short in one or more of these criteria; however, introduction of micro-anotechnology concepts, as well as synergistic coupling of complementary method(s), can improve performance and applicability of a particular approach, overcoming barriers to practical implementation. For this reason, we emphasize these strategies in examining recent advances in development of delivery systems.
机译:有效的细胞内递送严重阻碍了所有加工规模的研究和治疗应用。长期以来,物理递送方法已经证明了将货物分子直接递送至细胞质或细胞核的能力,并且对最常见方法(显微注射,电穿孔和声穿孔)的机理进行了广泛研究。在这篇综述中,我们讨论了已建立的方法以及新兴技术(磁转染,光注射和组合方式)。除了操作原理和实施策略外,我们还要解决各种体外,离体和体内平台的适用性和局限性。重要的是,我们对(1)各种细胞类型和所运送货物分子的治疗效果进行严格评估,(2)对不同处理规模(从单细胞到大种群)的适用性,(3)自动化/与现有工作流程集成的适用性, (4)复用潜力和灵活性/适应性,以实现不同细胞类型的处理之间的快速转换。现有技术通常不能满足这些条件中的一项或多项。但是,引入微/纳米技术概念以及互补方法的协同耦合可以提高特定方法的性能和适用性,克服了实际实施的障碍。因此,我们在检查交付系统开发的最新进展时会强调这些策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号